What is the USPSTF stance on lung cancer screening for high-risk individuals?

Prepare for the USPSTF Guidelines Test with comprehensive flashcards and multiple choice questions, each question includes hints and explanations. Get ready for your exam with confidence!

Multiple Choice

What is the USPSTF stance on lung cancer screening for high-risk individuals?

Explanation:
Annual low-dose CT screening for adults at high risk reduces lung cancer mortality, which is why the USPSTF supports this approach. The guidance is based on evidence from large trials showing that yearly LDCT detects cancer earlier in those with substantial smoking histories and appropriate age ranges, leading to fewer deaths from lung cancer compared to no screening. Other tests like chest X-ray or MRI have not demonstrated a mortality benefit for screening and are not recommended for routine use in this context. When screening is offered to the right high-risk individuals, the benefits of early detection generally outweigh the potential harms (such as false positives and radiation exposure), making annual LDCT the best-supported option.

Annual low-dose CT screening for adults at high risk reduces lung cancer mortality, which is why the USPSTF supports this approach. The guidance is based on evidence from large trials showing that yearly LDCT detects cancer earlier in those with substantial smoking histories and appropriate age ranges, leading to fewer deaths from lung cancer compared to no screening. Other tests like chest X-ray or MRI have not demonstrated a mortality benefit for screening and are not recommended for routine use in this context. When screening is offered to the right high-risk individuals, the benefits of early detection generally outweigh the potential harms (such as false positives and radiation exposure), making annual LDCT the best-supported option.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy